Massachusetts Wealth Management Astrazeneca PLC Transaction History
Massachusetts Wealth Management
- $159 Billion
- Q3 2024
A detailed history of Massachusetts Wealth Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Massachusetts Wealth Management holds 2,900 shares of AZN stock, worth $190,327. This represents 0.14% of its overall portfolio holdings.
Number of Shares
2,900
Previous 2,900
-0.0%
Holding current value
$190,327
Previous $226 Million
0.1%
% of portfolio
0.14%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.13 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.76 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.42 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.27 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...